Drugs Made In America Acquisition Corp. Rights

Drugs Made In America Acquisition Corp. Rights

DMAAR
Drugs Made In America Acquisition Corp. RightsUS flagNASDAQ Global Select
0.12
USD
+0.00
- -
263.65MMarket Cap

Total Valuation

Drugs Made In America Acquisition Corp. Rights carries a market capitalization of 263.65M, placing it among publicly traded companies globally.

Market Cap263.65M
Enterprise ValueN/A

Stock Price Statistics

Drugs Made In America Acquisition Corp. Rights's stock has declined approximately -43.33333% over the past 52 weeks. The 50-day moving average sits at 0.13, while the 200-day moving average is 0.12.

Beta (5Y)N/A
52-Week Price Change-43.33333%
50-Day Moving Average0.13
200-Day Moving Average0.12
Average Volume (20 Days)N/A